These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36184873)

  • 1. Nanovaccines to combat virus-related diseases.
    Wu F; Qin M; Wang H; Sun X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1857. PubMed ID: 36184873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
    Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.
    Saied AA; Nascimento MSL; do Nascimento Rangel AH; Skowron K; Grudlewska-Buda K; Dhama K; Shah J; Abdeen A; El-Mayet FS; Ahmed H; Metwally AA
    J Med Virol; 2022 Oct; 94(10):4599-4610. PubMed ID: 35655326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.
    Ferreira G; Santander A; Savio F; Guirado M; Sobrevia L; Nicolson GL
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166264. PubMed ID: 34481867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH funding for vaccine readiness before the COVID-19 pandemic.
    Kiszewski AE; Cleary EG; Jackson MJ; Ledley FD
    Vaccine; 2021 Apr; 39(17):2458-2466. PubMed ID: 33781600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in vaccine delivery systems against viral infectious diseases.
    Kim D; Wu Y; Kim YB; Oh YK
    Drug Deliv Transl Res; 2021 Aug; 11(4):1401-1419. PubMed ID: 33694083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Materials-based vaccines for infectious diseases.
    Bo Y; Wang H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1824. PubMed ID: 35708013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era.
    Dzuvor CKO; Tettey EL; Danquah MK
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1785. PubMed ID: 35238490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting B cell immunity against infectious diseases using nanovaccines.
    Singh A
    Nat Nanotechnol; 2021 Jan; 16(1):16-24. PubMed ID: 33199883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika.
    Abernathy ME; Dam KA; Esswein SR; Jette CA; Bjorkman PJ
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Vaccine Technologies to Combat Outbreak Situations.
    Rauch S; Jasny E; Schmidt KE; Petsch B
    Front Immunol; 2018; 9():1963. PubMed ID: 30283434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2.
    Lee KM; Lin SJ; Wu CJ; Kuo RL
    Biomed J; 2023 Feb; 46(1):70-80. PubMed ID: 36642222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity.
    Tursi NJ; Xu Z; Kulp DW; Weiner DB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1880. PubMed ID: 36807845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
    Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K
    Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design.
    Cai X; Li JJ; Liu T; Brian O; Li J
    Brief Funct Genomics; 2021 Sep; 20(5):289-303. PubMed ID: 34089044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.